|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide corresponding to a region within amino acids 142 and 205 of MAD2L1 (Uniprot ID#Q13257)|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 40% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunocytochemistry (ICC)||See 1 publications below|
PA5-21594 targets MAD2 in immunoprecipitation, immunocytochemistry, immunofluorescence, immunohistochemistry (paraffin), and Western blot applications and shows reactivity with Human samples. For immunohistochemistry (paraffin), antigen retrieval using heat mediated 10 mM citrate buffer (pH 6.0) or Tris-EDTA buffer (pH 8.0) is recommended.
The PA5-21594 immunogen is a synthetic peptide corresponding to a region within amino acids 142 and 205 of MAD2L1 (Uniprot ID#Q13257).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
PA5-21594 was used in immunocytochemistry to elucidate the mechanism by which BI2536 induces defects in cell proliferation of non-small cell lung cancer
|Choi M,Kim W,Cheon MG,Lee CW,Kim JE||Cancer letters (357:591)||2015|